42C
vs
FTSE Straits Times Singapore
Over the past 12 months, 42C has outperformed FTSE Straits Times Singapore, delivering a return of -58% compared to the FTSE Straits Times Singapore's 0% growth.
Stocks Performance
42C vs FTSE Straits Times Singapore
Performance Gap
42C vs FTSE Straits Times Singapore
Performance By Year
42C vs FTSE Straits Times Singapore
IX Biopharma Ltd
Glance View
iX Biopharma Ltd. engages in the development and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. The firm is focused on the development and commercialization of therapies for diseases of the central nervous system using patent protected formulations for sublingual delivery. The company developed a patented drug delivery platform technology, WaferiX. WaferiX delivers drug sublingually via the mucosa for better absorption, faster onset of action and predictable effect. Its delivery platform is particularly useful for drug repurposing. The firm operates in two segments, namely Specialty Pharmaceutical and Nutraceutical segments. Specialty Pharmaceutical primary business activities are the development, manufacturing and sale of pharmaceutical and nutraceutical products. Nutraceutical primary business activities are the sale of nutraceutical products. The firm's pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management.